Organigram Global Inc.
General ticker "OGI" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $179.1M (TTM average)
Organigram Global Inc. follows the US Stock Market performance with the rate: 53.1%.
Estimated limits based on current volatility of 2.4%: low 1.41$, high 1.48$
Factors to consider:
- Total employees count: 2 as of 2019
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-09-30 to 2027-09-30
- 2025-09-30 to 2026-09-30 estimated range: [1.40$, 2.58$]
- 2026-09-30 to 2027-09-30 estimated range: [1.31$, 2.46$]
Financial Metrics affecting the OGI estimates:
- Positive: with PPE of -5.5 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -1.33 <= 0.01
- Positive: 42.68 < Shareholder equity ratio, % of 62.10 <= 64.29
- Positive: -3.43 < Return on assets ratio (scaled to [-100,100]) of -3.07
- Positive: Industry inventory ratio change (median), % of -0.58 <= -0.16
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Inventory ratio change, % of 0 <= 0
Short-term OGI quotes
Long-term OGI plot with estimates
Financial data
| YTD | 2024-09-30 | 2025-09-30 |
|---|---|---|
| Operating Revenue | CA$159.84MM | CA$186.09MM |
| Operating Expenses | CA$195.51MM | CA$249.50MM |
| Operating Income | CA$-35.67MM | CA$-63.41MM |
| Non-Operating Income | CA$-9.77MM | CA$35.74MM |
| R&D Expense | CA$11.20MM | CA$10.95MM |
| Income(Loss) | CA$-45.44MM | CA$-27.66MM |
| Taxes | CA$0.00MM | CA$-9.89MM |
| Profit(Loss)* | CA$-45.44MM | CA$-10.79MM |
| Stockholders Equity | CA$305.99MM | CA$349.13MM |
| Assets | CA$407.86MM | CA$562.21MM |
| Operating Cash Flow | CA$3.87MM | CA$-4.30MM |
| Capital expenditure | CA$5.34MM | CA$12.22MM |
| Investing Cash Flow | CA$-38.77MM | CA$-59.35MM |
| Financing Cash Flow | CA$107.78MM | CA$28.24MM |
| Earnings Per Share** | CA$-0.48 | CA$-0.08 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.